Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 19;94(20):e2099-e2108.
doi: 10.1212/WNL.0000000000009435. Epub 2020 Apr 23.

Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease

Affiliations

Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease

Tatyana Sarycheva et al. Neurology. .

Abstract

Objective: To evaluate the risk of death in relation to incident antiepileptic drug (AED) use compared with nonuse in people with Alzheimer disease (AD) through the assessment in terms of duration of use, specific drugs, and main causes of death.

Methods: The MEDALZ (Medication Use and Alzheimer Disease) cohort study includes all Finnish persons who received a clinically verified AD diagnosis (n = 70,718) in 2005-2011. Incident AED users were identified with 1-year washout period. For each incident AED user (n = 5,638), 1 nonuser was matched according to sex, age, and time since AD diagnosis. Analyses were conducted with Cox proportional regression models and inverse probability of treatment weighting (IPTW).

Results: Nearly 50% discontinued AEDs within 6 months. Compared with nonusers, AED users had an increased relative risk of death (IPTW hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.12-1.36). This was mainly due to deaths from dementia (IPTW HR, 1.62; 95% CI, 1.42-1.86). There was no difference in cardiovascular and cerebrovascular deaths (IPTW HR, 0.98; 95% CI, 0.67-1.44). The overall mortality was highest during the first 90 days of AED use (IPTW HR, 2.40; 95% CI, 1.91-3.03). Among users of older AEDs, relative risk of death was greater compared to users of newer AEDs (IPTW HR, 1.79; 95% CI, 1.52-2.16).

Conclusion: In older vulnerable patients with a cognitive disorder, careful consideration of AED initiation and close adverse events monitoring are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flowchart of exclusion criteria of the study cohort with Alzheimer disease diagnoses
AED = antiepileptic drug.

Similar articles

Cited by

References

    1. Hickman RA, Faustin A, Wisniewski T. Alzheimer disease and its growing epidemic: risk factors, biomarkers, and the urgent need for therapeutics. Neurol Clin 2016;34:941–953. - PMC - PubMed
    1. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1151–1210. - PMC - PubMed
    1. Sarycheva T, Taipale H, Lavikainen P, et al. . Incidence and prevalence of antiepileptic medication use in community-dwelling persons with and without Alzheimer's disease. J Alzheimers Dis 2018;66:387–395. - PMC - PubMed
    1. tPerucca E, Berlowitz D, Birnbaum A, et al. . Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 2006;68(suppl 1):S49–S63. - PubMed
    1. Lavikainen P, Taipale H, Tanskanen A, et al. . Antiepileptic drugs and accumulation of hospital days among persons with Alzheimer’s disease. J Am Med Directors Assoc 2019;20:751–758. - PubMed

Publication types

Substances